A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

In pharma, you can take a larger slice of the healthcare pie than your peers, but…

The World Needs New Antibiotics, but the Business Model Is Broken

New drugs to defeat “superbug” bacteria aren’t reaching patients.

The World Needs New Antibiotics, but the Business Model Is Broken

New drugs to defeat “superbug” bacteria aren’t reaching patients.

Big Pharma’s Battle With the Biden Administration Could Have Legs

Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the…

Big Pharma Bets Big on China

China remains attractive to global pharmaceutical companies, even as many multinationals are turning their attention elsewhere.

FDA Approves First RSV Drug to Protect All Infants From Virus

While the virus often causes mild, cold-like symptoms, it is the leading cause of hospitalization of…

FTC warns nearly 700 companies about possible penalties for misleading claims

cmo today Marketers to review their practices to avoid potentially risking fines of up to hundreds…

FTC Alerts Nearly 700 Companies About Potential Penalties for Misleading Claims

cmo today Marketers to review their practices to avoid potentially risking fines of up to hundreds…

U.S. Appeals Court Sides With Drugmakers on Discount Program

Business Health care Health Drug makers can limit shipments to hospitals and clinics of drugs subsidized…

AstraZeneca to Buy U.S. Cardiorenal-Drug Maker

For an initial $1.3 billion, the Anglo-Swedish company will acquire CinCor Pharma, including the rights to…